Dr. Markus Yashavant Mapara, MD

  • New York, NY
  • Medical oncologist
NPI1093786766PAC ID4688688930
Medicare services, 2024
244
Medicare patients, 2024
49
Part D claims, 2024
16
Publications
65
Clinical trials
2
Practice address
622 W 168th St, New York, NY 10032
Practice phone
Call (212) 297-4255
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Columbia University Irving Medical Center

New York, New York

See all 6 affiliations

Find Dr. Mapara's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Markus Yashavant Mapara is a medical oncologist in New York, New York

Dr. Mapara practices at Columbia University Irving Medical Center in New York, New York.

Dr. Mapara's NPI, 1093786766, was assigned on January 30, 2006. Dr. Mapara graduated from University of Heidelberg Faculty of Medicine in 1990. Dr. Mapara holds New York license 263243.

NPI and contact details
Medicare PAC ID
4688688930
NPI enumeration date
January 30, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(212) 297-4255
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
62
Medical school graduation
1990

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Markus Yashavant Mapara practices at Columbia University Irving Medical Center in New York, New York

Dr. Mapara's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

  • Columbia University Irving Medical Center
    622 W 168th St, New York, NY 10032 · New York CountyPhone(212) 297-4255

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Markus Yashavant Mapara is affiliated with 4 sites of care and 2 medical groups

Dr. Mapara's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Mapara is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Mapara to 2 more group practices and clinics and 1 medical group, each named with a free account.

See all 6 affiliations for Dr. Mapara

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Markus Yashavant Mapara's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mapara practices, 3 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Columbia University Irving Medical CenterAvailable with a free account
+3 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Mapara practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Markus Yashavant Mapara is one of 458 medical oncologists in New York

Medical oncology is Dr. Mapara's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Mapara is board certified in hematology/oncology by the Internal Medicine. Dmand AI has Dr. Mapara's licenses on file in 2 states: New York and Pennsylvania.

Specialties and state licenses

  • Medical oncology, New YorkPrimaryLicense 263243 · 2011 to 2027 · taxonomy 207RX0202X
  • Pennsylvania license2005 to 2014

Clinical focus

Dmand AI lists acute respiratory failure, chronic diabetes and gastrointestinal infection among the conditions Dr. Mapara treats.

Medical oncologists near Dr. Mapara

Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Markus Yashavant Mapara billed Medicare for 244 services in 2024

CMS data shows 244 Medicare services from Dr. Mapara across 3 procedure codes in 2024, for 49 Medicare patients. Medicare paid $25,897 for them.

Medicare services, 2024244
Medicare patients49
Paid by Medicare$25,897
Procedure codes3

Dr. Mapara's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 2462024: 18923%
Other services
2023: 02024: 55

Where Dr. Mapara's Medicare services took place, 2024

  • In an office16568%
  • In a facility7932%

Dr. Mapara compared with the New York median for medical oncologists, 2024

  • Dr. Mapara
  • New York median
Medicare services
244vs 34028% below
Medicare patients
49vs 11256% below
Part D claims
12vs 13091% below

Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.

Dr. Mapara's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Mapara

Need commercial claims for Dr. Mapara?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Mapara and other medical oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Markus Yashavant Mapara treated 49 Medicare patients in 2024, average age 64

CMS counts 49 Medicare patients who saw Dr. Mapara in 2024. The largest group is 65 to 74, with 29 patients. 69% of them have high blood pressure, and 63% have high cholesterol. 27% are also on Medicaid. Their average risk score is 3.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mapara's median patient age at 69, with 43% women.

Medicare patients, 202449
Average age64
Average risk score3.56
Also on Medicaid27%

Dr. Mapara's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Mapara's Medicare patients by sex, 2024

  • Women2143%
  • Men2857%

Chronic conditions among Dr. Mapara's Medicare patients, 2024

  1. High blood pressure69%
  2. High cholesterol63%
  3. Arthritis51%
  4. Diabetes45%
  5. Chronic kidney disease41%
  6. Anxiety31%
  7. Mood disorders31%
  8. Ischemic heart disease29%

Share of Medicare patients with each condition. A patient can have several.

Dr. Mapara's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women43%
  • Men57%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Markus Yashavant Mapara wrote 16 Medicare Part D claims in 2024

In 2024, Dr. Mapara wrote 16 Medicare Part D claims. 75% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $8,852 in total drug cost. In 2019, CMS named 23 claims across 1 drug.

Part D claims, 202416
Drugs named by CMS1
Total drug cost$8,852

Dr. Mapara's Part D claims by kind of drug, 2024

  • Generic12 claims75%
  • Brand-name and other4 claims25%

Dr. Mapara's most prescribed drugs by claims, 2021

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2019 to 2021

  • 2019
  • 2021
Claims for drugs CMS names
2019: 232021: 1248%

Drugs named by CMS: 1 in 2021, 1 in 2019.

See all prescribing by Dr. Mapara

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Markus Yashavant Mapara scored 100 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mapara for performance year 2024, reported through an alternative payment model (APM). Dr. Mapara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mapara as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Mapara's MIPS scores, performance year 2024

  • 100of 100Final score
  • 85.3of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find medical oncologists like Dr. Mapara by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Markus Yashavant Mapara has 65 publications on record

Dmand AI links 65 papers to Dr. Mapara, published from 2005 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Hematopoietic Stem Cell Transplantation, Multiple Myeloma and Immunoglobulin Light-chain Amyloidosis. Dr. Mapara has published most often in Blood. Dr. Mapara's most frequent co-authors are Suzanne Lentzsch, MD, Divaya Bhutani, MD and Mathew Shane Maurer, MD.

Papers65
Years published2005 to 2025

Dr. Mapara's papers by year, 2013 to 2025

Topics Dr. Mapara writes about most

  • Hematopoietic Stem Cell Transplantation
  • Multiple Myeloma
  • Immunoglobulin Light-chain Amyloidosis
  • Anemia, Sickle Cell
  • Antibodies, Monoclonal
  • Antineoplastic Combined Chemotherapy Protocols
  • Signal Transduction
  • Thalidomide

Dr. Mapara's most frequent co-authors

Recent publications by Dr. Mapara

See all 65 publications and co-authors

See who Dr. Mapara researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Mapara works with, so you can find a warm path to the right medical oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Markus Yashavant Mapara has worked on 2 clinical trials

Dmand AI links Dr. Mapara to 2 clinical trials. Conditions studied include Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Lymphoma, Non-Hodgkin and Lymphoma.

Clinical trials with Dr. Mapara by phase

  1. 1Phase 1: 1 trial
  2. NonePhase 2: no trials
  3. 1Phase 3: 1 trial
  4. NonePhase 4: no trials

Conditions in Dr. Mapara's trials

  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Lymphoma, Non-Hodgkin
  • Lymphoma
  • Myeloproliferative Disorders

Investigators on the most trials with Dr. Mapara

Recent clinical trials with Dr. Mapara

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Markus Yashavant Mapara received $46,637 in industry payments from 2016 to 2025

CMS Open Payments shows 58 general payments to Dr. Mapara from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 78% of the total. Incyte Corporation paid the most, $25,344.

General payments to Dr. Mapara by program year, 2016 to 2025

General payments to Dr. Mapara by kind, 2016 to 2025

$46.6Kin total
  • Consulting fees$36,56378%
  • Travel and lodging$4,1779%
  • Honoraria$3,2007%
  • Food and beverage$2,6976%

Companies that paid Dr. Mapara the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Mapara

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Markus Yashavant Mapara graduated from University of Heidelberg Faculty of Medicine

Dr. Mapara graduated from University of Heidelberg Faculty of Medicine in 1990. Dr. Mapara is a member of American Society of Blood and Marrow Transplantation and ASH.

  1. Medical schoolUniversity of Heidelberg Faculty of Medicine
  2. Board certified in hematology/oncologyInternal Medicine

Source: Dmand AI Professional Profile Data

Dr. Markus Yashavant Mapara accepts plans from 11 insurance carriers

Dr. Mapara is in network with 11 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

Plan types Dr. Mapara accepts, by number of carriers

  1. PPO9
  2. Medicare8
  3. POS4
  4. EPO3
  5. HMO3
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Markus Yashavant Mapara's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Markus Yashavant Mapara

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Markus Yashavant Mapara's NPI number?

Dr. Markus Yashavant Mapara's NPI number is 1093786766. It was assigned on January 30, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Markus Yashavant Mapara?

Dr. Markus Yashavant Mapara is a medical oncologist in New York, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).

Where does Dr. Markus Yashavant Mapara practice?

Dr. Mapara practices at 622 W 168th St, New York, NY 10032. Dr. Mapara's primary practice is Columbia University Irving Medical Center in New York, New York. Dmand AI also links Dr. Mapara to 2 group practices and clinics and 1 medical group.

What is Dr. Markus Yashavant Mapara's office phone number?

The practice phone on file for Dr. Mapara is (212) 297-4255.

What is Dr. Markus Yashavant Mapara's medical license number?

Dr. Mapara holds New York license 263243, one of the licenses on file in 2 states.

Which states has Dr. Markus Yashavant Mapara been licensed in?

Dmand AI has state licenses on file for Dr. Mapara in New York (2011 to 2027) and Pennsylvania (2005 to 2014).

Which hospitals is Dr. Markus Yashavant Mapara affiliated with?

Dr. Mapara is affiliated with NewYork-Presbyterian/Weill Cornell Medical Center.

What medical group is Dr. Markus Yashavant Mapara part of?

Dr. Mapara is linked to ColumbiaDoctors. Dmand AI links Dr. Mapara to 1 more medical group.

Does Dr. Markus Yashavant Mapara accept Medicare?

Yes. CMS data shows Dr. Mapara billed Medicare for 244 services in 2024, and Dr. Mapara accepts Medicare assignment.

Does Dr. Markus Yashavant Mapara offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Mapara as offering telehealth services.

Show 11 more questionsShow fewer questions

What is Dr. Markus Yashavant Mapara's MIPS score?

Dr. Mapara's MIPS final score for performance year 2024 is 100 out of 100, reported through an alternative payment model (APM).

How many Medicare patients does Dr. Markus Yashavant Mapara see?

CMS counts 49 Medicare patients who saw Dr. Mapara in 2024, with an average age of 64.

Is Dr. Markus Yashavant Mapara board certified?

Yes. Dr. Mapara is board certified in hematology/oncology by the Internal Medicine.

What services does Dr. Markus Yashavant Mapara bill to Medicare?

In 2024, Dr. Mapara's most billed Medicare services were office visit, established patient (99215), hospital inpatient care (99233) and medicare service (G2211).

Where did Dr. Markus Yashavant Mapara go to medical school?

Dr. Mapara graduated from University of Heidelberg Faculty of Medicine in 1990.

What drugs does Dr. Markus Yashavant Mapara prescribe most?

In 2021 Medicare Part D data, Dr. Mapara's most prescribed drugs by claims were Entecavir.

Has Dr. Markus Yashavant Mapara received payments from drug or device companies?

CMS Open Payments shows $46,637 in general payments to Dr. Mapara from 11 companies from 2016 to 2025. The largest total came from Incyte Corporation.

How long has Dr. Markus Yashavant Mapara been practicing?

Dr. Mapara graduated from medical school in 1990, 36 years ago.

Does Dr. Markus Yashavant Mapara do research?

Dmand AI links 65 publications to Dr. Mapara, published from 2005 to 2025. Dr. Mapara has worked on 2 clinical trials.

Who does Dr. Markus Yashavant Mapara publish with?

Dr. Mapara's most frequent co-authors are Suzanne Lentzsch, MD (27 shared papers), Divaya Bhutani, MD (14 shared papers) and Mathew Shane Maurer, MD (11 shared papers).

What insurance does Dr. Markus Yashavant Mapara accept?

Dr. Mapara is in network with 11 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

Selling to medical oncology practices?

See medical oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)